Entities

Hani Goodarzi is publicly listed by Fusion Fund as Distinguished Scholar Network Member (network affiliation). His research combines machine learning and computational biology to investigate cancer progression and gene regulation. He earned a quantitative and computational biology PhD at Princeton; his Arc Institute and own LinkedIn sources corroborate the native person’s identity. Outside affiliations are included as published career context, not independently asserted new employment appointments.

Global nonprofit supporting healthspan science through research grants and early-stage investments. Equity investments remain distinct from grant funding.

Italian Angels for Growth (IAG) is an Italian nonprofit business-angel association founded in2007. It supports members investing collectively through deal-specific clubs, with a professional operating team and separate volunteer governance. Its published legal identifiers are Codice Fiscale97483410151 and VAT07117360961. The current website footer lists Corso Magenta59,20123Milan; its privacy policy retains the older ViaCamperio4A address, so the precise registered-address transition is unverified. The association is a network, rather than proof that every attributed investment was paid by its own balance sheet or a pooled VC fund. The published sectors are Life Science, Deep Tech, Digital and Fintech. Its public portfolio includes neurotechnology and rehabilitation, biotechnology, AI and software businesses. Restorative Neurotechnologies financing announcements explicitly identify IAG members/network participation; named deal champions are not automatically personal cash investors. The professional staff, board and Executive Committee are kept separate from180 publicly named external angel members. A member’s published corporate biography is source-qualified and does not assert every employer position remains current. Unnamed screening-committee seats and private members are not invented. The about page’s EUR550M+ figure combines members and co-investors, rather than actual capital raised by the association or a closed LP fund. Typical club-deal ticket ranges likewise are not individual checks. Eden Ventures is a separate pre-seed programme/investment-company initiative launched with members in2022; its specific legal vehicle and capital close require separate verification and are not fabricated as an IAG investment fund.

Modi Ventures invests in startups and venture funds at the intersection of AI, biology and medicine, including drug discovery, diagnostics, genomics, cell therapies and medical technology.

Founder and CEO of Ridecell.

Co-founder of Replit.

Co-founder and CTO of Ridecell.

Co-founder of Robinhood.

Co-founder and VP Engineering of Regatta Data.

Co-founder of Replit.

Co-founder and CEO of SeeTree.

Co-founder of Ready.

Co-founder of Safe and president of the Safe Ecosystem Foundation.

Co-founder of Rubedo Life Sciences.

Co-founder of Ready.

Co-founder of Replimune.

Co-founder of Safe and foundation council member.

Co-founder and CEO of Revv.

Co-founder of Replimune.

Co-founder and COO of Revv.

Vice president of the Safe Ecosystem Foundation.

Co-founder and CTO of RockMelt.

Co-founder and CEO of Robinhood.

Founder and CEO of Real.

Co-founder and CEO of Regatta Data.

Founder and CEO of QueryPie.

Founder and CEO of Radiant.

Co-founder and CTO of Regatta Data.

Co-founder and CEO of RecordGram.

Co-founder and co-chairman of Re:Build Manufacturing.

Co-founder and CTO of Pythagora.

Co-founder and CEO of Re:Build Manufacturing.

Co-founder and CFO of QueryPie.

Co-founder and chief scientist of Quantum Circuits.

Co-founder of RecordGram.

Co-founder and co-chairman of Re:Build Manufacturing.

Co-founder of RecordGram.

Co-founder of Pythagora.

Omnes is the French private-equity and infrastructure manager retained here under the historical Omnes Capital brand, legally OMNES SAS (SIREN428711196, Paris; AMF portfolio-management authorisation GP00-028 dated28August2000). Its own history traces Crédit Lyonnais/Crédit Agricole roots to1999 and the independent Omnes Capital rebrand to2012; those milestones are not guessed legal incorporation dates. Its current four activities cover energy-transition infrastructure, digital infrastructure, co-investments and deeptech/venture growth. The public directory names70 current professionals across investment, investor relations, legal, compliance, finance, communications and operations. Historical healthcare venture investments include Newronika adaptive deep-brain stimulation, Therapixel AI breast imaging and SeqOne genomic medicine; contemporary deeptech includes AI, quantum, defence, robotics and new space. The firm’s own September25,2019 announcement expressly names Omnes as Newronika EUR8.4M SeriesA lead, with individual allocation unpublished. Current AUM and EUR8M manager share capital are not LP fund close amounts. Its October2023 SFDR disclosure identifies44 legal fund vehicles, including parallel FPCI/SLP structures and co-investment vehicles; legal names and historical vintages do not establish present fund lifecycle or actual closing days. Actual first, second and final closes are separately qualified. Capenergie5’s reported EUR2.05B final total includes co-investments, so no precise standalone vehicle corpus is invented. Capenergie4’s contemporaneous EUR660M final close is preserved rather than replacing it with a later EUR900M retrospective amount. Four directory members have no published portrait in their official cards; those gaps remain explicit. This manager is distinct from the unrelated Omnes compute-note issuer and other similarly named financial companies. All prior personal/institutional participations, cash and roles are preserved.

Co-founder of MentAd.

Co-founder of Minimalist.

Co-founder of Minimalist.

Co-founder of MentAd.

Co-founder of Magic.

Co-founder of Magic Instruments.

Founder and CEO of MedHOK, now MHK.

Co-founder and CEO of magicpin.

Co-founder and CEO of Magic Instruments.

Co-founder of magicpin.

Co-founder of The Marshmallow Project.

Chairman and CEO of Masergy.

Founder of Mend.

Co-founder of The Marshmallow Project.

Co-founder of Magmatic Games.

Co-founder of Magmatic Games.

Co-founder and CEO of Lost Lake Games.

Co-founder and art leader at Lost Lake Games.

Co-founder and CTO of Magic Instruments.

Co-founder and engineering leader at Lost Lake Games.

Co-founder and CEO of Magdrive.

Co-founder of Meanwhile.

Co-founder of Magic.

Founder and CEO of Mandel AI.

Co-founder of Lithos Carbon.

Co-founder and CTO of Magdrive.

Co-founder and CEO of Meanwhile.

Co-founder and chief scientific officer of Lithos Carbon.

Chief executive of Link-A-Media Devices.

Co-founder and CEO of Lithos Carbon.

Co-founder of Lightbend.

Co-founder of Lightbend and creator of Akka.

Co-founder of Lightbend and creator of Scala.

Justin Kan is a technology entrepreneur and investor known for co-founding Justin.tv and Twitch. His own Goat Capital site identifies him as a team member. SignalFire’s January2025 Qualified Health investment article explicitly names him as an angel participant. Existing Justin.tv and DeepInfra relationships are preserved; his personal Qualified Health check is not attributed to Goat Capital or Twitch. A usable authentic portrait was not verified in the sources retrieved for this financing audit.

Tusk Ventures is Bradley Tusk’s regulatory, communications and strategic investment platform, currently identifying Tusk Holdings as its parent. Its own chronology distinguishes the original equity-for-services activity in 2012–2016, the traditional Tusk Venture Partners funds in 2016–2024, and renewed Tusk Ventures V2 activity from 2025. It earns equity for regulatory work and may make selective balance-sheet investments or raise deal-specific SPVs, as explained in the founder’s February 2025 statement. It works on AI, digital health, biotech and other technologies confronting emerging regulatory frameworks. The current primary roster names eleven executives, communications staff and advisers. Published case studies include healthcare AI Doctronic and Ro, but a client or regulatory case study is not automatically a disclosed cash investment. Exact underlying legal contracting entity and investment vehicle are not established for every brand-named check; Tusk Holdings is a parent affiliation rather than a duplicate investor. The similarly named SEC adviser Tusk Ventures Management LLC CRD 300907 is a separately reported legal entity; no unsupported blanket legal identity or fund-allocation bridge is imposed. The existing traditional Tusk Venture Partners Investor 4242 and all historical/private records remain separate and preserved. No fourth flagship LP close is claimed, and traditional fund commitments are recorded only on that fund-manager profile. The Biological Computing Company’s 2026 primary seed announcements literally name Tusk Ventures; precise subscribing vehicle and individual allocation are undisclosed.

Software executive and former SolidWorks CEO with long experience commercializing 3D design and engineering platforms.

CVS Health Ventures is the dedicated corporate venture-investment programme of CVS Health, launched in2021 to back healthcare technology and care-delivery businesses aligned with the enterprise strategy. Its current mandate spans early-stage direct venture investments, minority growth equity, limited-partner investments and market development that helps portfolio companies work with CVS businesses. Its own investment themes include technology-enabled workflows, responsible AI and automation, consumer-centered health and reducing complexity in access, care and payment. Current published portfolio examples include ambient clinical-AI company Abridge, voice-AI/vocal-biomarker company Ellipsis Health, autism-care provider Cortica, neurodegenerative-disease care platform Synapticure, behavioral-health companies Nema and SpectrumAi, and other healthcare businesses. Technology and clinical-outcome statements remain attributed to their publishers rather than independent evidence of efficacy. The current public venture-team directory publishes26 investment, operations and administrative professionals, led by Managing Partner Vijay Patel; these are unit roles, not a cloned roster of CVS Health’s corporate board. The2021 launch announced an initialUSD100M corporate allocation, which is distinct from outside LP cash raised or a verified fund close. A current partner biography’s overUSD1B invested-portfolio figure includes direct and LP holdings, rather than a new financing event. The public venture brand is verified but precise subscribing subsidiaries and legal names of all investment vehicles are not disclosed; CVS Health parent record remain separate and no automatic duplicate payer is inferred.

Bow Capital is an early-stage venture capital firm founded in partnership with the University of California Board of Regents. It backs founders building physical, industrial and biological AI, including robotics and industrial automation, autonomous defense and navigation systems, commerce and freight networks, and technologies for diagnostics, drug discovery and healthcare operations. The firm primarily invests from seed through Series A and connects companies with UC researchers, technical experts, operators and commercial partners to move scientific advances into products. Its published core portfolio combines investments from Bow Capital Funds I and II; the website also describes a UC San Diego incubator supporting national-security science, robotics and advanced manufacturing.

Entrepreneurship education and accelerator platform with a fund investing in selected alumni companies.

Co-founder and CTO of Rune.

Founder and CEO of Speechify.

Co-founder and CEO of Volansi.

CEO of Observe.

Founder of Vahan.ai.

Founder of Prellis Biologics.

CEO of Prellis Biologics.

Co-founder and CEO of Qualia.

Co-founder and CEO of Talon Cyber Security.

Co-founder and CTO of Talon Cyber Security.

Founder of REXS.io.

Co-founder of Latent Health.

Co-founder and CEO of Linc’well.

Co-founder of Rune.

Co-founder and CTO of SafetyWing.

Co-founder and CEO of SafetyWing.

Co-founder of Latent Health.

Co-founder of Volansi.

Co-founder of Nyctale.

Co-founder and CEO of OP Games.

Co-founder and CEO of Nova Credit.

Co-founder of Nova Credit.

Co-founder of Nyctale.

Co-founder and CEO of ModRetro.

Glen Tullman co-founded 7wire Ventures and serves as a partner. The firm’s current biography also names him CEO of Transcarent, whose care-navigation platform combines clinicians and generative AI. He previously founded and led Livongo, and held chief-executive roles at Allscripts and Enterprise Systems. His investment and operating experience covers digital care, chronic-condition management and healthcare software. Existing personal investment records and outside roles are retained; institutional company checks are not assigned to him personally.

Public- and private-markets technology investor focused on AI, software, internet, and fintech companies.

Dropbox co-founder and former chief technology officer who is now active as a private technology investor.

Early-stage technology investor and former Facebook product designer who co-founded Form Capital.

Venture investor focused on consumer and marketplace companies, with prior investing experience at Accel and Battery Ventures.

Venture investor and former startup operator with experience at Reddit, Twitter, and Riverside Ventures.

Deep-tech venture investor backing companies in climate, computing, health, and frontier science.

Internet entrepreneur, community-product strategist, and investor who builds and acquires online businesses through Late Checkout.

Fintech entrepreneur and investor who co-founded Open and previously worked on financial products at Google and Square.

Community-platform entrepreneur who founded Meetup and has since worked on civic, cooperative, and local-community projects.

Software entrepreneur and angel investor associated with consumer and social-technology startups.

Technology entrepreneur and angel investor who co-founded digital asset-management platform Air and leads its product and engineering work.

Enterprise-data and AI entrepreneur who co-founded Cloudera and now leads retrieval-augmented-generation platform Vectara.

Computer engineer, Sun Microsystems co-founder, and technology investor who founded Arista Networks and leads its systems architecture.

Early-stage venture investor focused on frontier technologies including AI, robotics, space, and advanced computing.

Insurance and financial-services executive with experience leading public and private companies and advising technology businesses.

Technology investor and operator who founded Canas Capital to back software and internet businesses.

Thomas Wolf co-founded Hugging Face and serves as its chief science officer, and is a strategic adviser to Bioptimus.

Technology investor who founded DST Global and co-founded the Breakthrough Prize and Breakthrough Initiatives science programs.

Samsung Electronics is a South Korean electronics and semiconductor manufacturer founded in 1969. Its Device eXperience division develops smartphones, tablets, wearables, televisions, home appliances, network equipment and connected-device services; its Device Solutions division designs and manufactures memory chips, system semiconductors and foundry products. The group also operates display and automotive/audio technology businesses through subsidiaries. Its AI work spans on-device assistants, smart appliances, advanced memory and semiconductor manufacturing, enterprise AI integration and robotics. The corporation makes strategic equity investments and acquisitions, including leading Mistral AI’s September 2026 Series D. Samsung Electronics is distinct from the Samsung Venture Investment Corporation investment manager.

French finance and insurance executive, former AXA chair, and governance leader across corporate and public-interest organizations.

French financial-services executive and investor who previously served as Société Générale group chief operating officer and led AXA's Asian operations.

Cybersecurity entrepreneur and former CIA analyst who co-founded Coalition to combine cyber insurance with active risk management.

Cybersecurity researcher, creator of Nessus, and co-founder of Tenable, where he leads long-term technology strategy.

Errik Anderson is an Alumni Ventures board director and investor-advisory-council member. He founded and leads Alloy Therapeutics and co-founded biotechnology companies including Adimab, Compass Therapeutics and Alector. He also founded Ulysses Diversified Holdings and co-owns the New England Free Jacks. His education includes Dartmouth engineering and business schools. Council membership is a separately published advisory affiliation.

Private-equity pioneer who co-founded KKR and continues to lead the firm at the board level.

Serial technology entrepreneur and investor who founded Silicon Graphics, co-founded Netscape, and helped create Healtheon/WebMD.

Entrepreneur and investor who built Broadcast.com, became a longtime Shark Tank investor, and co-founded Cost Plus Drugs.

Investor, author, and media strategist focused on games, virtual worlds, platforms, and the evolution of the internet.

Casino-resort entrepreneur who founded and led major Las Vegas hospitality businesses including Mirage Resorts and Wynn Resorts.

French telecommunications entrepreneur and technology investor who founded iliad and Station F and backs startups through Kima Ventures.

MassMutual Ventures is a venture investment platform backed by life insurer MassMutual, its sole limited partner. It invests in enterprise software, financial technology, cybersecurity, health technology and climate technology, and helps founders through capital, commercial introductions and access to MassMutual’s real estate, energy assets and investment networks. Its climate strategy backs early-stage companies combining software, AI and physical technologies to improve the performance and resilience of energy systems, buildings, infrastructure and natural resources. The current central team publishes climate investment specialists, enterprise investors and operating staff; regional partnerships are identified separately.

Professional basketball player, entrepreneur, producer, and technology investor who co-founded Thirty Five Ventures.

Software entrepreneur who co-founded Datadog and leads the observability and security platform as chief executive.

Sports-business executive, producer, and investor who manages Kevin Durant's business interests and co-founded Thirty Five Ventures.

501(c)(3) private philanthropic foundation that makes grants. Associated entities may make investments; foundation and affiliate attribution should be verified separately.

Automotive executive and mobility investor who is the great-grandson of Henry Ford and serves as executive chair of Ford Motor Company.

Geoffrey von Maltzahn is publicly identified by Lila as CEO. Co-founded Lila after founding leadership at Generate, Tessera, Quotient and Indigo. Trained in biomedical engineering and medical physics at MIT, with an additional UC San Diego degree.

Noubar Afeyan is publicly identified by Lila as Board Member. Founder and CEO of Flagship Pioneering and a Lila co-founder. The launch-era founding-chair designation is historical: Lila’s current roster names John Kim as chair and lists Afeyan as a board member.